Article
Genomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment.
Expert review of hematology - 1 Aug 2010
Fertrin Kleber Yotsumoto, Costa Fernando Ferreira
Abstract excerpt
Sickle cell disease (SCD) is one of the best characterized human monogenic disorders. The development of molecular biology allowed the identification of several genomic polymorphisms responsible for its clinical diversity. Research on the first genetic modulators of SCD, such as coinheritance of α-thalassemia and haplotypes in the β-globin gene cluster, have been followed by studies associating single nucleotide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
